These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8983938)

  • 1. In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging.
    Normann PT; Hals PA
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):307-13. PubMed ID: 8983938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and stability of caldiamide sodium in rats.
    Okazaki O; Kurata T; Yoshioka N; Hakusui H
    Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
    Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
    Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.
    Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H
    Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantitation of gadolinium chelates in human serum and urine by high-performance liquid chromatography and post-column derivatization of gadolinium with Arsenazo III.
    Hvattum E; Normann PT; Jamieson GC; Lai JJ; Skotland T
    J Pharm Biomed Anal; 1995 Jun; 13(7):927-32. PubMed ID: 8562618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transfer and milk secretion of gadodiamide injection in rats.
    Okazaki O; Murayama N; Masubuchi N; Nomura H; Hakusui H
    Arzneimittelforschung; 1996 Jan; 46(1):83-6. PubMed ID: 8821524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
    Berg KJ; Lundby B; Reinton V; Nordal KP; Rootwelt K; Smith HJ
    Nephron; 1996; 72(2):212-7. PubMed ID: 8684529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.
    Van Wagoner M; Worah D
    Invest Radiol; 1993 Mar; 28 Suppl 1():S44-8. PubMed ID: 8486503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain.
    Kucharczyk J; Asgari H; Mintorovitch J; Vexler Z; Rocklage S; Watson A; Moseley M
    AJNR Am J Neuroradiol; 1993; 14(2):289-96. PubMed ID: 8456701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination of serum calcium.
    Normann PT; Frøysa A; Svaland M
    Scand J Clin Lab Invest; 1995 Aug; 55(5):421-6. PubMed ID: 8545600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
    Schuhmann-Giampieri G; Schmitt-Willich H; Frenzel T; Schitt-Willich H [corrected to Schmitt-Willich H]
    J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
    Puttagunta NR; Gibby WA; Smith GT
    Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.
    VanWagoner M; O'Toole M; Worah D; Leese PT; Quay SC
    Invest Radiol; 1991 Nov; 26(11):980-6. PubMed ID: 1743922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced MRI with gadodiamide injection in rat disease models.
    Yamada K; Miyahara K; Sato H; Nakayama W; Sato M; Hirose T; Kato H; Ikehira H; Tateno Y; Sugihara H; Furuhama K
    J Vet Med Sci; 1996 Apr; 58(4):291-5. PubMed ID: 8741259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study.
    Fretellier N; Idée JM; Dencausse A; Karroum O; Guerret S; Poveda N; Jestin G; Factor C; Raynal I; Zamia P; Port M; Corot C
    Invest Radiol; 2011 May; 46(5):292-300. PubMed ID: 21263333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of dysprosium in monkey serum by inductively-coupled plasma atomic emission spectrometry (ICP-AES) after the administration of Sprodiamide Injection, a new contrast medium for magnetic resonance imaging.
    Lai JJ; Jamieson GC
    J Pharm Biomed Anal; 1993; 11(11-12):1129-34. PubMed ID: 8123724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.